Phase 4 N=41 Octaplas Pediatric Plasma Exchange Trial
Adverse Effects in the Therapeutic Use of Plasma Substitutes
Primary: Monitoring of Adverse Drug Reactions Caused by the Octaplas™Used for Plasma Exchange. — 0; 5; 3; 8 event
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=259 Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
Arthritis, Rheumatoid
Primary: Part 1: Number of Participants With Low Disease Activity (LDA) by Visit — 0; 17; 37; 163 Participants — p==0.242
Phase 4 N=83 Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
Schizophrenia
Primary: Medication Adherence — 1.1; 1.9 units on a scale — p==.05
Phase 4 N=27 Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
Heart Failure, Congestive
Primary: LVEF (Left Ventricular Ejection Fraction) — 24; 28; 25; 24 percent ejection fraction — p=0.025
Phase 4 N=465 Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Heart Failure and Reduced Ejection Fraction
Primary: Change From Baseline in Aortic Characteristic Impedance at Week 12 — -0.7; -2.9 dyne x sec/cm5 — p=0.7827
Phase 4 N=135 Quality of Recovery After Dexamethasone, Ondansetron or Placebo Intrathecal Morphine Administration
Fractures, Bone · Nausea and Vomiting, Postoperative · Pruritus
Primary: Quality of Recovery — 184; 187; 185 Score on a scale
Phase 4 N=30 Spinal Cord Stimulation (SCS) Dosing Study
Back Pain · Leg Pain
Primary: SCS Therapy Satisfaction — 6; 2; 1; 0 Participants
Phase 4 N=814 A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Primary: Change From Baseline to Week 24 in Hemoglobin A1c (HbA1c) — -2.158; -2.000 Percentage of HbA1c — p=0.1009
Phase 4 N=50 A Low Dose Remifentanil Infusion During Tracheal Extubation in Surgical Intensive Care Unit Patients
Tracheal Extubation
Primary: Mean Arterial Pressure Changes During Extubation — 94; 97; 96; 97 mmHg
Phase 4 N=200 The Effect of Sugammadex Versus Neostigmine on Postoperative Pulmonary Complications
Postoperative Complications · Neuromuscular Blockade
Primary: Number of Participants With a Postoperative Pulmonary Complication — 33; 40 Participants
Phase 4 N=120 Subject Satisfaction With AbobutulinumtoxinA Treatment
Glabellar Frown Lines
Primary: Subject Satisfaction When Treated With abobutulinumtoxinA in Their Glabellar Lines — 66; 38; 4; 2 Participants
Phase 4 N=150 Intravenous Lidocaine and Ketorolac for Pain Management
Pain
Primary: Pain Score at 30 Minutes — 5.52; 3.88; 3.14 score on a scale
Phase 4 N=60 Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period
Congenital Bleeding Disorder · Haemophilia A
Primary: Occurrence of Confirmed FVIII Inhibitor Development (≥ 0.6 BU) — 0; 0 Participants
Phase 4 N=300 Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Atrial Fibrillation
Primary: Number of Patients With Clinically-Significant Bleeding — 14; 17 Participants
Phase 4 N=40 Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia
Emergence Delirium
Primary: Pediatric Anesthesia Emergence Delirium Score — 18; 18 units on a scale